Biological Co-Processor for Neural Signal Tracking

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current systems fail to quantitatively detect and track the progression of neurological diseases and the efficacy of treatments, as they do not consider the initial state of neuronal-brain regions or interplay, leading to incomplete conclusions and inadequate diagnosis and management of neurological disorders.

Innovation Solution

A Biological Co-Processor (BCP) device that uses advanced nanotechnology, optogenetics, and deep machine learning to read and write neural signals, allowing for bidirectional communication with the brain, enabling the recording and modulation of neuronal activity, and providing a closed-loop system for dynamic analysis and treatment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional systems are used to record neuronal data, then data collection is simple, but the systems cannot quantitatively detect and track the progression of neurological diseases or treatment efficacy

Engineering Contradiction:
Improvequantitative detection capabilityVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The BCP implements a closed-loop feedback system that continuously monitors neuronal activity, compares it against baseline data, and adjusts treatment parameters in real-time. This enables quantitative tracking of disease progression and treatment efficacy by measuring changes in neuronal signals over time and using this information to modulate stimulation parameters dynamically.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The BCP acts as an intermediary device between the neuronal tissue and external control systems. It receives raw neuronal signals, processes them through onboard computing resources, and translates them into actionable insights for disease tracking and treatment adjustment, bridging the gap between simple recording and complex analysis.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Speed

If the BCP device is implanted for direct neuronal interaction, then real-time bidirectional communication is achieved, but surgical intervention and implantation risks increase

Engineering Contradiction:
Improvereal-time communication speedVSAvoidsurgical risks
Core Design Contradiction:
SpeedVSObject-affected harmful factors

Solution Approach 1:

The BCP replaces mechanical/electrical recording methods with optical detection using voltage-sensitive dyes and fluorescence imaging. This substitution enables real-time monitoring of neuronal membrane potential changes without requiring invasive electrode implantation, thereby achieving high-speed communication while reducing surgical risks and tissue damage.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system uses optical fields as an intermediary to detect and communicate with neuronal tissue. Instead of direct electrical contact that requires surgery, the BCP uses light to probe neuronal activity and deliver optical stimulation, creating a non-invasive interface between the device and the nervous system.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Manufacturing precision

If advanced nanotechnology and optogenetics are used for precise neuronal modulation, then treatment precision is improved, but device complexity and manufacturing difficulty increase

Engineering Contradiction:
Improveneuronal modulation precisionVSAvoiddevice manufacturing ease
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The BCP achieves precise neuronal modulation by dynamically adjusting multiple parameters including optical wavelength, fluorescence excitation intensity, and stimulation timing. These parameter changes enable fine-tuned control of neuronal activity without requiring complex nanoscale device structures, simplifying manufacturing while maintaining high precision.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The system replaces complex mechanical nanoscale structures with optical and chemical mechanisms. Instead of using nanoscale electrodes or mechanical actuators that are difficult to manufacture, the BCP uses voltage-sensitive dyes, optical fields, and fluorescence imaging to achieve precise neuronal modulation with simpler, more manufacturable components.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Measurement precision

If continuous monitoring and closed-loop control are implemented, then disease tracking accuracy is improved, but energy consumption increases

Engineering Contradiction:
Improvedisease tracking accuracyVSAvoiddevice energy consumption
Core Design Contradiction:
Measurement precisionVSUse of energy by moving object

Solution Approach 1:

The BCP implements periodic monitoring cycles rather than continuous operation. It alternates between measurement phases where fluorescence signals are captured and analysis phases where data is processed and treatment parameters are adjusted. This periodic operation maintains high tracking accuracy while reducing average power consumption by keeping the system in low-power states between measurement cycles.

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The system maintains continuous useful action through efficient use of the fluorescence signal. Once excitation is applied, the BCP captures the entire fluorescence decay curve continuously, extracting maximum information from each excitation event. This eliminates the need for repeated excitations and reduces overall energy consumption while maintaining continuous monitoring capability.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables comprehensive understanding and management of neurological disorders by providing real-time, quantitative data on brain function and dysfunction, allowing for potential therapeutic interventions and improved diagnosis, including treatment of conditions like PTSD, chronic pain, and epilepsy.

Implementation Method 1

receive neuronal signals from brain tissue

Methodology Applied
Scientific EffectElectrical conduction: Conduction (electrical)

Implementation Method 2

transmit optical and electrical signals to brain tissue

Methodology Applied
Scientific EffectOptical signal transmission: Light

Implementation Method 3

transmit optical and electrical signals to brain tissue

Methodology Applied
Scientific EffectElectrical signal transmission: Electric Field

Data Source

PatentUS11957897B2Biological co-processor (BCP)
Publication Date: 2024.04.16 GENESIS INTELLIGENCE LLC
  • US11957897B2 patent drawing
  • US11957897B2 patent drawing
  • US11957897B2 patent drawing

AI summary

Embodiments may provide a general-purpose, relatively inexpensive, AI-driven implant that is able to adapt to and modulate any given neuron, circuit, or region in the brain, as well as individual cells of any type of tissue. For example, in an embodiment, a method for interacting with living tissue may comprise attaching a device to a body of a person or animal, the device comprising plurality of carbon fibers in contact with the living tissue, receiving by the carbon fibers signals from the living tissue, processing the received signals by the device, and transmitting the processed signals.